Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00219570
Status:
COMPLETED
Last Update Posted:
2011-05-11
First Post:
2005-09-13
Brief Title:
Dalacin-T Gel Post Approval Study
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase IV Clinical Study Of Clindamycin Phosphate Topical Gel In The Treatment Of Acne Vulgaris
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate in a comparison vs Acuatim cream nadifloxacin cream the efficacy and safety of Dalacin T Gel clindamycin phosphate gel as a therapeutic medication for acne vulgaris in acne vulgaris patients including children ages 13 and up in order to clarify the clinical positioning of Dalacin T Gel
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None